Clinical cases in transplantation.
A series of cases are presented to illustrate the complexity of the care of immunocompromised patients with established invasive fungal infections. These discussions by an expert panel serve to identify areas of controversy and for future research in the care of transplant recipients.
Fishman
J A
JA
Harvard Medical School, Transplant Infectious Diseases and Compromised Host Program, Infectious Disease Division and Transplant Unit, Massachusetts General Hospital, Boston, Massachusetts, USA. jfishman@partners.org
Kubak
B M
BM
D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000494:pharmacology / Q000627:therapeutic use; D001232:Aspergillus fumigatus / Q000187:drug effects / Q000472:pathogenicity; D002175:Candida / Q000472:pathogenicity; D041221:Candida glabrata / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity; D005260:Female; D015725:Fluconazole / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000166:cytology / Q000382:microbiology* / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000473:pathology; D016040:Lung Transplantation / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000209:etiology*; D012852:Sinusitis / Q000188:drug therapy / Q000382:microbiology; D014180:Transplantation / Q000009:adverse effects*
D000666:Amphotericin B; D015725:Fluconazole